LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 84TH LEGISLATIVE REGULAR SESSION May 6, 2015 TO: Honorable Myra Crownover, Chair, House Committee on Public Health FROM: Ursula Parks, Director, Legislative Budget Board IN RE:HB2908 by Parker (Relating to authorizing patients with certain terminal illnesses and severe chronic diseases to access certain investigational drugs, biological products, and devices that are in clinical trials.), Committee Report 1st House, Substituted No significant fiscal implication to the State is anticipated. The bill would amend the Health and Safety Code to allow eligible patients access to investigational drugs, biological products, or devices if certain conditions are met. The bill would authorize certain actions by manufacturers, health insurers, and physicians to ensure access to such products. The Health and Human Services Commission and Texas Medical Board indicate that rulemaking activities could be accomplished using existing resources. The Department of State Health Services indicates that there may be a cost for the treatment of patients in certain facilities. It is assumed that the costs could be absorbed within available resources. The Texas Department of Criminal Justice and Department of Aging and Disability Services indicate that the provisions of the bill could be implemented using existing resources. Local Government Impact No fiscal implication to units of local government is anticipated. Source Agencies:323 Teacher Retirement System, 327 Employees Retirement System, 454 Department of Insurance, 503 Texas Medical Board, 529 Health and Human Services Commission, 537 State Health Services, Department of, 539 Aging and Disability Services, Department of, 696 Department of Criminal Justice LBB Staff: UP, ADe, NB, WP, VJC, TWh, EMo, ER
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 84TH LEGISLATIVE REGULAR SESSION
May 6, 2015
TO: Honorable Myra Crownover, Chair, House Committee on Public Health FROM: Ursula Parks, Director, Legislative Budget Board IN RE:HB2908 by Parker (Relating to authorizing patients with certain terminal illnesses and severe chronic diseases to access certain investigational drugs, biological products, and devices that are in clinical trials.), Committee Report 1st House, Substituted
TO: Honorable Myra Crownover, Chair, House Committee on Public Health
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: HB2908 by Parker (Relating to authorizing patients with certain terminal illnesses and severe chronic diseases to access certain investigational drugs, biological products, and devices that are in clinical trials.), Committee Report 1st House, Substituted
Honorable Myra Crownover, Chair, House Committee on Public Health
Honorable Myra Crownover, Chair, House Committee on Public Health
Ursula Parks, Director, Legislative Budget Board
Ursula Parks, Director, Legislative Budget Board
HB2908 by Parker (Relating to authorizing patients with certain terminal illnesses and severe chronic diseases to access certain investigational drugs, biological products, and devices that are in clinical trials.), Committee Report 1st House, Substituted
HB2908 by Parker (Relating to authorizing patients with certain terminal illnesses and severe chronic diseases to access certain investigational drugs, biological products, and devices that are in clinical trials.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
The bill would amend the Health and Safety Code to allow eligible patients access to investigational drugs, biological products, or devices if certain conditions are met. The bill would authorize certain actions by manufacturers, health insurers, and physicians to ensure access to such products. The Health and Human Services Commission and Texas Medical Board indicate that rulemaking activities could be accomplished using existing resources. The Department of State Health Services indicates that there may be a cost for the treatment of patients in certain facilities. It is assumed that the costs could be absorbed within available resources. The Texas Department of Criminal Justice and Department of Aging and Disability Services indicate that the provisions of the bill could be implemented using existing resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: 323 Teacher Retirement System, 327 Employees Retirement System, 454 Department of Insurance, 503 Texas Medical Board, 529 Health and Human Services Commission, 537 State Health Services, Department of, 539 Aging and Disability Services, Department of, 696 Department of Criminal Justice
323 Teacher Retirement System, 327 Employees Retirement System, 454 Department of Insurance, 503 Texas Medical Board, 529 Health and Human Services Commission, 537 State Health Services, Department of, 539 Aging and Disability Services, Department of, 696 Department of Criminal Justice
LBB Staff: UP, ADe, NB, WP, VJC, TWh, EMo, ER
UP, ADe, NB, WP, VJC, TWh, EMo, ER